Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
This report contains market size and forecasts of POC Diagnostics in global, including the following market information:
Global POC Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global POC Diagnostics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five POC Diagnostics companies in 2021 (%)
The global POC Diagnostics market was valued at 26410 million in 2021 and is projected to reach US$ 48270 million by 2028, at a CAGR of 9.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Glucose Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of POC Diagnostics include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter and Nipro Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the POC Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global POC Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global POC Diagnostics Market Segment Percentages, by Type, 2021 (%)
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Global POC Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global POC Diagnostics Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Laboratory
Others
Global POC Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global POC Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies POC Diagnostics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies POC Diagnostics revenues share in global market, 2021 (%)
Key companies POC Diagnostics sales in global market, 2017-2022 (Estimated), (K Units)
Key companies POC Diagnostics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech